KEQU
Kewaunee ScientificANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
FY2026 revenue growth, slightly higher full-year EBITDA, and progress integrating Nu Aire indicate that the expanded laboratory-products platform can grow despite project timing and cost pressures [#SEC-8K-2026-06-23].
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Coverage is low, with no analyst targets, revision tape, or meaningful social context available.
Momentum
75
Value
72
Sentiment
50
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $35.80 · Bull $43.80 · Bear $30.50
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Why
Momentum75 · Δ7d -
Value72 · Δ7d -0.1
Sentiment50 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
75
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
72
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.1
Sentiment
50
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 74.8 / Value 72.0 / Sentiment 50.0
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$109.32M
Beta
0.56
Shares Out
2.87M
P/E (TTM)
9.8
P/S (TTM)
0.39
P/FCF (TTM)
5.88
Rev YoY
+3.3%
EPS YoY
-48.7%
Gross Margin
+28.9%
Op Margin
+6.9%
Net Debt
$60.41M
Current Ratio
2.12
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology